Related Experiment Video
Updated: Jul 20, 2026

10:01
Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes
Published on: February 11, 2015
The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector
1Molecular Medicine Program and Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Gene Therapy
|April 21, 2006
Summary
Retroviral particles can be delivered to tumors via T cells, utilizing a novel mechanism dependent on T-cell activation and perforin. This bypasses the need for engineered viral envelopes for gene delivery.
Area of Science:
- Immunology
- Virology
- Gene Therapy
Background:
- Retroviral particles attached to T cells can be transported to metastases through adoptive transfer, termed 'viral hitchhiking'.
- Viral particles typically infect tumor cells via envelope/receptor-dependent interactions after T-cell accumulation at tumor sites.
Purpose of the Study:
- To investigate a novel, envelope/receptor-independent pathway for viral particle transfer from T cells to tumor cells.
- To explore the potential of T-cell-mediated viral delivery for gene therapy applications.
Main Methods:
- Investigated T-cell activation-dependent viral transfer mechanisms.
- Utilized retroviral particles (MLV) and analyzed their interaction with activated T cells and tumor cells.
- Assessed the role of perforin in releasing viral particles from endosomes.
Main Results:
- Identified a second pathway for viral transfer independent of viral envelope and tumor cell receptors.
- Demonstrated that T-cell activation and the endosomolytic property of perforin facilitate viral particle release from endosomes.
- Showed that MLV particles lacking viral envelopes can be effectively transferred via T cells.
Conclusions:
- A novel mechanism of viral transfer exploits the immunological synapse, independent of viral envelope proteins.
- This T-cell-mediated delivery system offers a new strategy for in vivo gene delivery, bypassing the need for viral envelope engineering.
- Findings present opportunities to enhance adoptive T-cell therapy efficacy and target vectors for systemic gene delivery.
Related Concept Videos
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

